Hot Topic: Bladder Cancer: New Agents In The Setting Of Unequal Access Across The World

Co-Chair(s)

• 

  Mario Fernandez

  Associate Professor
  Clínica Alemana Universidad del Desarrollo, Chile
• 

  Stephen Williams

  Associate Chief Medical Officer, Med Director High Value Care, Professor and Chief of Urology
  University of Texas Medical Branch, USA, Texas, United States

Presentations:

• 14:00 - 14:15 CET

  Rapidly Evolving Treatment Landscape in BC. What Are the Reasonable Thresholds for a Drug to Become the New Standard?
  

  Speaker: Piyush K. Agarwal – University of Chicago
• 14:15 - 14:30 CET

  Clinical and Logistical Challenges of Perioperative Systemic Therapy for MIBC in Emerging Regions
  

  Speaker: Karima Oualla – Hassan II University Hospital
• 14:30 CET

  Panel 1. Global Practice Variation in NMIBC
• 14:30 - 14:38 CET

  What Is the Real Need for New Agents If BCG Treatment Is Adequate?
  

  Speaker: Mario I. Fernandez – Clínica Alemana Universidad del Desarrollo
• 14:38 - 14:46 CET

  Generic Agents as More Accessible Alternatives in Emerging Regions
  

  Speaker: Hammad Ather – Aga Khan University
• 14:46 - 14:54 CET

  New Drugs for NMIBC – Will They Be Cost Efficient?
  

  Speaker: Stephen B. Williams – University of Texas Medical Branch, USA, Texas
• 14:54 - 15:04 CET

  Discussion
• 15:04 CET

  Panel 2. Radical Cystectomy – Still the way to go in BCG-unresponsive NMBIC?
• 15:04 - 15:12 CET

  Early Cystectomy: A Value‑Driven Approach to Managing BCG‑Unresponsive NMIBC
  

  Speaker: Francisco Lopez
• 15:12 - 15:20 CET

  Early Cystectomy Optimizes Cancer Control and Quality of Life
  

  Speaker: Peter Black – University of British Columbia
• 15:20 - 15:30 CET

  Discussion